TickerFactsScreenerDevelopers

BIOCRYST PHARMACEUTICALS INC (BCRX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $604.0K2010: $325.0K2011: $55.0K2012: $113.0K2013: $30.0K2014: $106.0K2015: $5.12M2016: $5.28M2017: $328.0K2018: $366.0K2019: $343.0K2020: $514.0K2021: $2.38M2022: $1.35M2023: $2.17M2024: $1.12M2025: $2.47M$2.47M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$2.47M+119.6%
2024$1.12M-48.2%
2023$2.17M+60.5%
2022$1.35M-43.4%
2021$2.38M+364.0%
2020$514.0K+49.9%
2019$343.0K-6.3%
2018$366.0K+11.6%
2017$328.0K-93.8%
2016$5.28M+3.0%
2015$5.12M+4732.1%
2014$106.0K+253.3%
2013$30.0K-73.5%
2012$113.0K+105.5%
2011$55.0K-83.1%
2010$325.0K-46.2%
2009$604.0K—